Kelvin Stott

645 total citations
9 papers, 552 citations indexed

About

Kelvin Stott is a scholar working on Molecular Biology, Computational Theory and Mathematics and Physiology. According to data from OpenAlex, Kelvin Stott has authored 9 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Computational Theory and Mathematics and 3 papers in Physiology. Recurrent topics in Kelvin Stott's work include Alzheimer's disease research and treatments (3 papers), Computational Drug Discovery Methods (3 papers) and Protein Structure and Dynamics (1 paper). Kelvin Stott is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Computational Drug Discovery Methods (3 papers) and Protein Structure and Dynamics (1 paper). Kelvin Stott collaborates with scholars based in United Kingdom, Switzerland and United States. Kelvin Stott's co-authors include Andrew J. Doig, Jody M. Mason, Jonathan M. Blackburn, M. F. Perutz, P J Butler, Hozefa Amijee, M. F. Perutz, Yu Wai Chen, Rodrigo J. Carbajo and David Neuhaus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Kelvin Stott

9 papers receiving 541 citations

Peers

Kelvin Stott

MB

PHYSI

CMN

CTM

PHARM

Sigrid Schnoegl Germany

Leo W. Barrett United States

Claire J. Sarell United Kingdom

Shiori Tamamizu‐Kato United States

W.S. Wade United States

Isam Qahwash United States

Giorgio Favrin United Kingdom

Carsten Krantz Switzerland

Janine Kutzsche Germany

Cillian Byrne France

Sigrid Schnoegl Germany

Kelvin Stott

368 ×1.0

MB

320 ×1.4

PHYSI

115 ×0.7

CMN

85 ×1.0

CTM

74 ×1.0

PHARM

Citations per year, relative to Kelvin Stott Kelvin Stott (= 1×) peers Sigrid Schnoegl

Countries citing papers authored by Kelvin Stott

Since Specialization

Citations

This map shows the geographic impact of Kelvin Stott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelvin Stott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelvin Stott more than expected).

Fields of papers citing papers by Kelvin Stott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelvin Stott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelvin Stott. The network helps show where Kelvin Stott may publish in the future.

Co-authorship network of co-authors of Kelvin Stott

This figure shows the co-authorship network connecting the top 25 collaborators of Kelvin Stott. A scholar is included among the top collaborators of Kelvin Stott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelvin Stott. Kelvin Stott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Hampson, Lisa V., Björn Bornkamp, Björn Holzhauer, et al.. (2021). Improving the assessment of the probability of success in late stage drug development. Pharmaceutical Statistics. 21(2). 439–459. 12 indexed citations

2.

Stott, Kelvin, et al.. (2007). N-methylated peptide inhibitors of β-amyloid aggregation and toxicity. Proceedings of The Physiological Society. 8 indexed citations

3.

Stott, Kelvin, et al.. (2006). N-Methylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of the Inhibitor Structure. Biochemistry. 45(32). 9906–9918. 169 indexed citations

4.

Doig, Andrew J., Kelvin Stott, Hozefa Amijee, et al.. (2006). P4–300: N–methylated peptide inhibitors of β–amyloid aggregation. Alzheimer s & Dementia. 2(3S_Part_20). 1 indexed citations

5.

Doig, Andrew J., Kelvin Stott, & J. Mark Treherne. (2004). Inhibitors of Amyloid Aggregation: Technologies for the Discovery of Novel Lead Compounds. Biotechnology and Genetic Engineering Reviews. 21(1). 197–214. 3 indexed citations

6.

Mason, Jody M., et al.. (2003). Design strategies for anti-amyloid agents. Current Opinion in Structural Biology. 13(4). 526–532. 108 indexed citations

7.

Carbajo, Rodrigo J., et al.. (2001). Solution Studies of Chymotrypsin Inhibitor-2 Glutamine Insertion Mutants Show No Interglutamine Interactions. Biochemical and Biophysical Research Communications. 280(3). 855–860. 13 indexed citations

8.

Chen, Yu Wai, Kelvin Stott, & M. F. Perutz. (1999). Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat. Proceedings of the National Academy of Sciences. 96(4). 1257–1261. 51 indexed citations

9.

Stott, Kelvin, Jonathan M. Blackburn, P J Butler, & M. F. Perutz. (1995). Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases.. Proceedings of the National Academy of Sciences. 92(14). 6509–6513. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact